Dr. Roy Marcus, M.D

NPI: 1245278084
Total Payments
$2,998
2024 Payments
$239.73
Companies
26
Transactions
123
Medicare Patients
2,770
Medicare Billing
$735,422

Payment Breakdown by Category

Food & Beverage$2,959 (98.7%)
Education$38.69 (1.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,959 117 98.7%
Education $38.69 6 1.3%

Top Paying Companies

Company Total Records Latest Year
Relypsa, Inc. $735.46 33 $0 (2019)
Amgen Inc. $433.07 14 $0 (2024)
Otsuka America Pharmaceutical, Inc. $422.61 19 $0 (2022)
AstraZeneca Pharmaceuticals LP $207.07 7 $0 (2022)
Bayer Healthcare Pharmaceuticals Inc. $131.91 2 $0 (2024)
NxStage Medical, Inc. $130.81 2 $0 (2018)
CALLIDITAS THERAPEUTICS US INC. $116.11 2 $0 (2022)
BAXTER HEALTHCARE $100.00 1 $0 (2018)
Mallinckrodt LLC $97.81 5 $0 (2017)
Janssen Pharmaceuticals, Inc $84.58 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $239.73 2 Amgen Inc. ($131.37)
2022 $298.86 10 CALLIDITAS THERAPEUTICS US INC. ($116.11)
2021 $47.95 2 Otsuka America Pharmaceutical, Inc. ($47.95)
2020 $120.12 7 E.R. Squibb & Sons, L.L.C. ($29.85)
2019 $763.01 35 Relypsa, Inc. ($216.07)
2018 $874.76 31 Relypsa, Inc. ($288.39)
2017 $653.20 36 Relypsa, Inc. ($231.00)

All Payment Transactions

123 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
07/31/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $108.36 General
Category: Cardio-renal
04/17/2024 Amgen Inc. Aranesp (Biological) Food and Beverage In-kind items and services $131.37 General
Category: Nephrology
12/14/2022 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $15.76 General
Category: NEPHROLOGY
12/07/2022 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $93.98 General
Category: Nephrology
10/13/2022 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $33.31 General
Category: Hyperkalemia
10/06/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $23.55 General
Category: Cardio-renal
09/27/2022 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.60 General
Category: Cardiovascular and Metabolism
09/19/2022 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $22.13 General
Category: Nephrology
07/27/2022 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $20.13 General
Category: NEPHROLOGY
06/08/2022 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $24.62 General
Category: Hyperkalemia
05/23/2022 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $27.84 General
Category: Nephrology
05/16/2022 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.94 General
Category: Cardiovascular and Metabolism
12/08/2021 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $23.76 General
Category: NEPHROLOGY
08/19/2021 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $24.19 General
Category: NEPHROLOGY
08/11/2020 Cumberland Pharmaceuticals, Inc. Vaprisol Dextrose in Plastic Container (Drug) Food and Beverage In-kind items and services $17.70 General
Category: Nephrology
03/20/2020 Ultragenyx Pharmaceutical Inc. Cryvista (Drug) Food and Beverage In-kind items and services $18.82 General
Category: XLH Metabolic Bone Disorder
02/25/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.04 General
Category: Cardiovascular
02/24/2020 E.R. Squibb & Sons, L.L.C. NULOJIX (Biological) Food and Beverage Cash or cash equivalent $15.81 General
Category: Immunology
02/18/2020 Akcea Therapeutics, Inc. TEGSEDI (Drug) Food and Beverage In-kind items and services $20.10 General
Category: NEUROLOGY
02/11/2020 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $16.14 General
Category: Hyperparathyroidism
01/14/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $17.51 General
Category: NEPHROLOGY
12/17/2019 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $24.40 General
Category: Hyperkalemia
11/19/2019 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $23.66 General
Category: Hyperkalemia
11/14/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $106.29 General
Category: Cardiovascular and Metabolism
11/12/2019 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $15.16 General
Category: Hyperparathyroidism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 123 258 $150,784 $61,452
2022 8 483 1,023 $448,729 $164,453
2021 16 906 1,850 $635,820 $246,947
2020 16 1,258 2,415 $641,983 $262,570
Total Patients
2,770
Total Services
5,546
Medicare Billing
$735,422
Procedure Codes
46

All Medicare Procedures & Services

46 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 46 162 $116,316 $47,388 40.7%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 23 35 $20,930 $8,634 41.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 29 36 $5,832 $2,336 40.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 12 12 $4,248 $1,706 40.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 13 13 $3,458 $1,389 40.2%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 67 326 $247,168 $95,524 38.6%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 56 92 $57,809 $22,782 39.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 136 218 $59,876 $15,186 25.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 108 249 $37,396 $14,752 39.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 46 46 $19,172 $7,643 39.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 30 34 $13,133 $3,022 23.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 23 25 $7,105 $2,806 39.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 17 33 $7,070 $2,738 38.7%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 72 348 $256,704 $102,772 40.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 181 320 $86,651 $32,596 37.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 166 476 $70,385 $28,873 41.0%
90966 Home dialysis services per month, patient 20 years of age or older Office 2021 12 84 $50,464 $15,518 30.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 87 91 $37,350 $14,911 39.9%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 37 45 $27,783 $11,073 39.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 59 74 $28,143 $11,021 39.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 58 62 $17,241 $6,814 39.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 50 65 $13,560 $5,625 41.5%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 19 19 $8,598 $3,599 41.9%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 26 34 $8,492 $3,322 39.1%
99490 Chronic care management services, first 20 minutes of clinical staff time per calendar month Office 2021 19 80 $6,531 $2,606 39.9%

About Dr. Roy Marcus, M.D

Dr. Roy Marcus, M.D is a Nephrology healthcare provider based in Upland, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245278084.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Marcus, M.D has received a total of $2,998 in payments from pharmaceutical and medical device companies, with $239.73 received in 2024. These payments were reported across 123 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,959).

As a Medicare-enrolled provider, Marcus has provided services to 2,770 Medicare beneficiaries, totaling 5,546 services with total Medicare billing of $735,422. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Upland, PA
  • Active Since 06/03/2006
  • Last Updated 07/26/2012
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1245278084

Products in Payments

  • Veltassa (Drug) $793.39
  • JYNARQUE (Drug) $356.43
  • Parsabiv (Biological) $203.05
  • LOKELMA (Drug) $169.53
  • Aranesp (Biological) $155.65
  • Kerendia (Drug) $131.91
  • System One (Device) $130.81
  • TARPEYO (Drug) $116.11
  • Renal - Chronic (Device) $100.00
  • ACTHAR (Biological) $97.81
  • XARELTO (Drug) $84.58
  • SAMSCA (Drug) $77.97
  • NULOJIX (Biological) $69.13
  • Rayaldee (Drug) $62.52
  • Parsabiv (Drug) $52.03
  • AFINITOR (Drug) $49.13
  • FARXIGA (Drug) $37.54
  • FABRAZYME (Drug) $35.83
  • FERAHEME (Drug) $34.72
  • ELIQUIS (Drug) $25.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Upland